openPR Logo
Press release

Hunter Syndrome Treatment Market 2022 Size & Share | Market worth USD 1118.4 million with 6.0% CAGR by 2027

01-28-2022 08:06 AM CET | Health & Medicine

Press release from: Fortune Business Insights

Hunter Syndrome Treatment Market

Hunter Syndrome Treatment Market

The global “Hunter Syndrome Treatment Market” is predicted to reach USD 1,118.4 million by 2026, exhibiting a CAGR of 6.0% during the forecast period. The increasing R&D investments by key players for the development of novel therapies to treat rare diseases in patients will be critical factor in boosting the Hunter syndrome treatment market growth during the forecast period. Moreover, the rising clinical studies for diabetes and coronary artery disease (CAD) will have a positive impact on market during the forecast period.

In addition, the surge in rare and genetic diseases will uplift the Hunter syndrome treatment market share. According to the Genetic and Rare Diseases Information Center (GARD), there can be an estimated 7,000 rare diseases and the total number of individuals in the U.S. from these rare diseases can be 25-30 million.

According to the report, published by Fortune Business Insights, tiled “Hunter Syndrome Treatment Market Size, Share & Industry Analysis, By Treatment (Enzyme Replacement Therapy (ERT), and Others), By Route of Administration (Intravenous, and Intracerebroventricular (ICV)/ Intrathecal), By End User (Hospitals, Specialty Clinics and Others), and Regional Forecast, 2019-2026” the market size stood at USD 702.4 million in 2018. The Hunter syndrome treatment market report focuses on demonstrating a complete assessment of the market. It contains facts, thoughtful insights, historical information, industry-validated market information, and projections with a suitable set of assumptions and methodology. It offers valuable insights into all the notable developments of the market. It is created after extensive research followed by an all-encompassing analysis to benefit companies, stakeholders, financers, and potential investors. Moreover, it also includes product launches, acquisitions, collaborations and partnerships, and industry developments.

Get Request a Sample Copy of the Hunter Syndrome Treatment Report:
https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/hunter-syndrome-treatment-market-102536

What is the Scope of this market?
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.

Geographical Analysis:
• North America (The U.S. and Canada)
• Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and the Rest of Europe)
• Asia Pacific (Japan, China, India, Australia, Southeast Asia, and the Rest of Asia Pacific)
• Latin America (Brazil, Mexico, and the Rest of Latin America)
• The Middle East & Africa (South Africa, GCC, and the Rest of the Middle East & Africa)

Major Hunter Syndrome Treatment Market Key players covered in the report include:
• Shire (Takeda Pharmaceutical Company Limited)
• Denali Therapeutics
• ArmaGen
• Inventiva
• Green Cross Corp. (GC Pharma)
• CANbridge Life Sciences Ltd.

Hunter Syndrome Treatment Market Analysis 2022:
Competitive Landscape:

Agreement between Clinigen K.K. and GC Pharma to Enable Growth

Clinigen K.K, a Japanese licensed medical supplier, and GC Pharma, a biopharmaceutical company announced a licensing agreement for the manufacturing and commercialization of Hunterase (Idursulfase-beta) ICV, a human recombinant iduronate-2-sulfatase (IDS) used in enzyme replacement therapy for the treatment of Hunter syndrome. The agreement between the two companies can be a critical factor in fostering the growth of the market owing to the methods to aid severe patients and therefore improve their condition. Furthermore, Hunterase ICV will be directly delivered to cerebral ventricles by intracerebroventricular (ICV) administration, in order to reach the cells of the brain and central nervous system. Furthermore, Yoshikazu Nakamura, Representative Director at Clinigen K.K, said “Hunter Syndrome is a complex disease with unmet medical need. We earnestly hope that this product provides significant benefit to patients in Japan.” In addition, President at GC Pharma, Eun Chul, said in statement, “we are delighted to further enhance the value of Hunterase through this partnership, our efforts to make substantial differences in the lives of those with Hunter syndrome in all markets will continue by providing new treatment environments and opportunities.”

For More Information :
https://www.fortunebusinessinsights.com/hunter-syndrome-treatment-market-102536

Competitive Landscape:

The market in North America generated a revenue of USD 358.9 million in 2018 and is predicted to grow rapidly during the forecast period. The growth in the region is attributed to the high diagnosis and treatment for rare diseases. The growing reimbursement policies for therapies will have a positive impact on the market in the region.

Asia Pacific is predicted to witness high growth rate in the forthcoming years owing to the developing healthcare infrastructure. Also, the presence of major players in the region will bolster healthy growth in Asia Pacific. In addition, ongoing clinical trials will boost the Hunter syndrome treatment market trends in the forthcoming years. For instance, the Phase 1/2 clinical trial conducted and initiated by Prof. Torayuki Okuyama in National Center for Child Health and Development in Japan showed a significant decrease in Heparan sulfate which causes mental retardation.

Have Any Query? Ask Our Experts:https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/hunter-syndrome-treatment-market-102536

About Us:

Fortune Business Insights™ delivers accurate data and innovative corporate analysis, helping organizations of all sizes make appropriate decisions. We tailor novel solutions for our clients, assisting them to address various challenges distinct to their businesses. Our aim is to empower them with holistic market intelligence, providing a granular overview of the market they are operating in.

Contact Us:

Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.
Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email: sales@fortunebusinessinsights.com
LinkedIn: https://www.linkedin.com/company/fortune-business-insights
Facebook: https://www.facebook.com/FortuneBusinessInsightsPvtLtd

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Hunter Syndrome Treatment Market 2022 Size & Share | Market worth USD 1118.4 million with 6.0% CAGR by 2027 here

News-ID: 2539695 • Views: 237

More Releases from Fortune Business Insights

Carbon Black Market price is expected to showcase considerable growth by reachin …
As Per Report Published By Fortune Business Insights™ the global carbon black market price is expected to showcase considerable growth by reaching USD 17,027.1 million by 2027 while exhibiting a CAGR of 4.4% between 2020 and 2027. This growth is attributed to the rising rubber industry and the increasing incidence of road fatalities that is propelling the demand for advanced carbon black globally. This information is published by Fortune
Document Capture Software Market Industry Analysis, Size, Share, Trends, Demand, …
The global document capture software market size is expected to gain momentum from the increasing demand for Software-as-a-service based documents and software solutions. An unpublished report by Fortune Business Insights titled, "Document Capture Software Market Size, Share & Industry Analysis, By Deployment (On-Premise, Cloud-Based), By Solution (Multiple-channel Capture, Cognitive Capture, Mobile Capture), By Application Area (Retail, Banking, BFSI, Healthcare, IT, Telecom, Government, Other) and Regional Forecast, 2021-2028," discusses the prime
Oleochemicals Market size is expected to reach USD 52.04 billion by 2028 | Know …
The global oleochemicals market size is expected to reach USD 52.04 billion by 2028, exhibiting a CAGR of 6.4% between 2021 and 2028. The growing emphasis on natural oils & fats obtained from living feedstock, including plants, animals, and oilseeds, will enable speedy expansion of the market, states Fortune Business Insights, in a report, titled "Oleochemicals Market, 2021-2028." The market size stood at USD 31.42 billion in 2020. Get Sample PDF
Acrylonitrile Butadiene Styrene Market share is projected to reach USD 42,809.5 …
The global acrylonitrile butadiene styrene market share is projected to reach USD 42,809.5 million by 2027, exhibiting a CAGR of 6.9% during the forecast period. The phenomenal growth in the global construction industry will be a prime growth driver for this market, states Fortune Business Insights™ The construction industry has entered a phase of prolific expansion due to the rapid growth in world population and the proliferation of residential and

All 4 Releases


More Releases for Hunter

Hunter Syndrome Treatment Market Size, Share | Hunter Syndrome Treatment Industr …
Global Hunter Syndrome Treatment Market Report provides a detailed industry overview along with the analysis of Cost Structure, Supply Chain, Development Techniques, Retailers Analysis, Financial Support, business Strategies, Marketing Channels. Global Hunter Syndrome Treatment Market research report provides a point-by-point In-Depth analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, the impact of domestic and global market players, value chain
Hunter Syndrome Treatment Market Size, Share | Hunter Syndrome Treatment Industr …
Global Hunter Syndrome Treatment Market Report provides a detailed industry overview along with the analysis of Cost Structure, Supply Chain, Development Techniques, Retailers Analysis, Financial Support, business Strategies, Marketing Channels. Global Hunter Syndrome Treatment Market research report provides a point-by-point In-Depth analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, the impact of domestic and global market players, value chain
Hunter Syndrome Treatment Market Size - Forecasts to 2026
As per the research conducted by GME, the Hunter Syndrome Treatment Market will grow with a CAGR value of 7.5 percent by 2026. Elevated unfulfilled demands, a strong product or drug portfolio, increased understanding of this unusual disorder, and expanding research & development initiatives for the advancement of innovative therapies are likely to fuel market growth throughout the forecast period. Browse 151 Market Data Tables and 111 Figures spread through 181
Hunter Global Holdings Limited Investment Approach
Investment Analysis The majority of the modern investment world is built around the idea that savvy investors can utilize today's almost limitless informational resources, all-powerful analytical systems and tools together with the opinions of experts to beat the market. It seems to be a reasonable conclusion that this makes sense: By selecting the right stocks, employing the right broker, finding the right manager and predicting the right time to buy or sell,
Hunter Introduces The Original Tour Boot
Always on the forefront of functionality and style, Hunter is proud to introduce the new Original Tour Boot to their collection, their first rain boot designed to make traveling that little bit easier. The latest addition to Hunter Boot's renowned collection of rain boots has launched and it has one, very important difference; it's been designed with traveling in mind. The Original Tour Boot is Hunter's first travel-friendly rain boot, which
Wyboston Lakes Head Hunter Awarded Top European Accolade
International executive placement specialist Christopher Luttik has been recognised as one of the UK’s leading head hunters when he recently received a Bronze accolade from MRI Network, the oldest, largest and most successful recruitment organisations in the world. Presented at their recent convention in Madrid, Christopher came third out of over 250 European franchisees who find and place top flight specialists and key executives in leading international corporations.